 |
 |
Brucellosis
(Brucella melitensis, abortus, suis, and canis)
|
For comprehensive CDC information about bioterrorism
and related issues, please visit http://www.bt.cdc.gov.
|
MMWR Articles
CDC. Human Exposure to Brucella abortus Strain RB51--Kansas, 1997. MMWR March 47:172-174.
Links
http://www.aphis.usda.gov/vs/nahps/brucellosis
References
CDC. Human exposure to Brucella abortus strain RB51–Kansas, 1997.MMWR 1998;47:172-175.
US Department of Agriculture, Agricultural Research Service National Animal Disease Center, Iowa State University, Stevens, M G, Olsen SC, Palmer MV, Cheville NF. Brucella abortus strain RB51: A new brucellosis vaccine for cattle. Compendium 1997; 19:766-774.
Baldi PC, Miguel SE, Fossati, CA, Wallach JC. Serological follow-up of human brucellosis by measuring IgG Antibodies to lipoplysaccharide and cytoplasmic proteins of Brucella species. Clin Infect Dis 1996; 22:446-455.
Martin-Mazuelos E, Nogales MC, Florez C, Gomez-Mateos M, Lozano F, Sanchez A. Outbreak of Brucella melitensis among microbiology laboratory workers. J Clin Microbiol 1994; 32: 2035-2036.
Khuri-bulos NA, Doud AH, Azab SM. Treatment of childhood brucellosis: results of a prospective trial on 113 children. Pediatr Infect Dis J 1993; 12:377-381.
Ko J, Splitter GA. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev 2003; 16(1): 65-78.
Chomel BB, DeBess EE, Mangiamele DM, Reilly KF, Farver TB, Sun RK, Barrett LR. Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: a shift toward foodborne transmission. J Infect Dis 1994; 170:1216-1223.